ACE2 and COVID-19: Several authors have discussed the hypothesis that COVID-19 triggers a pro-inflammatory cytokine reaction, coupled with an upregulation in angiotensin-converting enzyme 2 (ACE2) expression, resulting in endothelial cell damage and, subsequently, thrombosis [16-18].